Oxford/AstraZeneca COVID-19 vaccine: one Indian man died
- Vitamin D supplementation may help strengthen Long-COVID recovery
- What bacteria and viruses can cause cancers?
- The world first TIL cell therapy targeting advanced melanoma is coming soon
- The Pros and Cons of Radiotherapy Affecting Antitumor Immunity
- Oral probiotics can enhance the effects of immunotherapy
- Genetic study reveals why one Scottish woman can’t feel pain and her wounds heal faster
Oxford/AstraZeneca COVID-19 vaccine: one Indian man died
Oxford/AstraZeneca COVID-19 vaccine: one Indian man died. India’s 45-year-old man died after being vaccinated with the COVID-19 vaccine: the second shot, everything was normal before vaccination.
Overseas Network, March 3-On March 2, a 45-year-old man in India became unconscious after receiving the second dose of the “Covishield” COVID-19 vaccine and was declared dead.
According to a report by the Hindustan Times on the 3rd, the deceased Sukhdev Kirdat was a driver of a private doctor and lived in Maharashtra. He was in a coma after being vaccinated at a local vaccination center for 20 minutes. He was rushed to the hospital but was pronounced dead.
This incident caused panic among other vaccinators. City officials claim that the cause of death can only be determined after the autopsy report is released.
The local health official KR Kharat said, “Everything was normal before the deceased was vaccinated, and his body has been sent to the hospital for an autopsy. Experts will study this and submit a cause of death report.
The staff checked all his past Physical condition records. In addition, after the first dose of the deceased was vaccinated, his body was completely normal without any abnormalities.” It is reported that the “Covishield” COVID-19 vaccine was jointly developed by the University of Oxford and AstraZeneca, and was developed by the Serum Institute of India produce
(source:internet, reference only)
Disclaimer of medicaltrend.org